Recombinant human activated protein C and strict glycemic control in sepsis: mutually exclusive strategies?
作者信息
Schultz M J, Levi M
出版信息
Minerva Anestesiol. 2009 Jul-Aug;75(7-8):415-6. Epub 2008 Jan 24.
PMID:19153552
Abstract
摘要
相似文献
1
Recombinant human activated protein C and strict glycemic control in sepsis: mutually exclusive strategies?重组人活化蛋白C与脓毒症的严格血糖控制：相互排斥的策略？
Minerva Anestesiol. 2009 Jul-Aug;75(7-8):415-6. Epub 2008 Jan 24.
2
Effects of recombinant human activated protein C on the fibrinolytic system of patients undergoing conventional or tight glycemic control.重组人活化蛋白C对接受常规或严格血糖控制患者纤溶系统的影响。
Minerva Anestesiol. 2009 Jul-Aug;75(7-8):417-26. Epub 2008 Jan 24.
3
Recombinant human-activated protein C (rhAPC) in childhood sepsis.重组人活化蛋白C（rhAPC）用于儿童脓毒症
J Intensive Care Med. 2004 Jan-Feb;19(1):56-7. doi: 10.1177/0885066603259583.
4
Recombinant human activated protein C (Xigris).重组人活化蛋白C（Xigris）
Int J Clin Pract. 2002 Sep;56(7):542-5.
5
[Activated protein C and treatment of sepsis].[活化蛋白C与脓毒症的治疗]
Tidsskr Nor Laegeforen. 2004 May 20;124(10):1422; author reply 1422-3.
6
[Treatment of severe sepsis and multiple organ failure with activated protein C].
Ugeskr Laeger. 2004 Mar 8;166(11):995.
7
Drotrecogin alfa (activated) (recombinant human activated protein C) reduces host coagulopathy response in patients with severe sepsis.重组人活化蛋白C（活化的）可降低严重脓毒症患者的宿主凝血障碍反应。
Thromb Haemost. 2003 Oct;90(4):642-53. doi: 10.1160/TH02-11-0270.
8
Recombinant human activated protein C.重组人活化蛋白C
Int J Antimicrob Agents. 2006 Aug;28(2):90-4. doi: 10.1016/j.ijantimicag.2006.05.021. Epub 2006 Jul 11.
9
[Activated protein C, coagulation, inflammation, and treatment of severe sepsis].[活化蛋白C、凝血、炎症与严重脓毒症的治疗]
Ned Tijdschr Geneeskd. 2001 Mar 31;145(13):613-6.
10
FDA approves first biologic treatment for sepsis.美国食品药品监督管理局批准了首个用于治疗败血症的生物制剂。
Dent Today. 2002 Mar;21(3):28, 30.
Zotero 插件